Overexpression of IGFBP3 is associated with poor prognosis and tumor metastasis in nasopharyngeal carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s13277-016-5400-8.pdf
Reference31 articles.
1. Chen ZT, Liang ZG, Zhu XD. A review: proteomics in nasopharyngeal carcinoma. Int J Mol Sci. 2015;16(7):15497–530. doi: 10.3390/ijms160715497 .
2. Jiang W, Liu N, XZ C, Sun Y, B L, XY R, et al. Genome-wide identification of a methylation gene panel as a prognostic biomarker in nasopharyngeal carcinoma. Mol Cancer Ther. 2015. doi: 10.1158/1535-7163.MCT-15-0260 .
3. Sasaki MM, Skol AD, Bao R, Rhodes LV, Chambers R, Vokes EE, et al. Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2015;24(8):1222–8. doi: 10.1158/1055-9965.EPI-15-0275 .
4. Liu S, Wang X, Shu J, Zhao Z, Sun Z, Luo B. Sequence analysis of EBV immune evasion gene BNLF2a in EBV associated tumors and healthy individuals from nasopharyngeal carcinoma endemic and non-endemic regions of China. J Med Virol. 2015;87(11):1946–52. doi: 10.1002/jmv.24254 .
5. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, Chan DK, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23(2):261–70.
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. EBV-positive glycoproteins associated with nasopharyngeal carcinoma;Pathology - Research and Practice;2024-08
2. MicroRNA-409: Molecular functions and clinical applications in cancer;Biochemistry and Biophysics Reports;2024-07
3. The role of IGFBP-3 in tumor development and progression: enlightenment for diagnosis and treatment;Medical Oncology;2024-05-07
4. IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion;Cancer Cell International;2024-02-07
5. IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancer;iScience;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3